897 results on '"Biemond, Bart J."'
Search Results
2. One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
3. The predictive value of the modified early warning score for admission to the intensive care unit in patients with a hematologic malignancy – A multicenter observational study
4. Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study
5. Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
6. Over 4 Years of Safety and Efficacy with Voxelotor in Patients with Sickle Cell Disease
7. Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study
8. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome
9. Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
10. Bleeding assessment following central venous catheter placement, a direct comparison of prospective and retrospective analyses.
11. Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling
12. Prevalence of autoimmune diseases in patients with sickle cell disease: a single center retrospective analysis
13. Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study
14. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
15. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
16. A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms
17. Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling
18. Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.
19. Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target.
20. Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease‐related organ complications: A systematic review and meta‐analysis.
21. Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
22. Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study
23. Contribution of Coagulopathy on the Risk of Bleeding After Central Venous Catheter Placement in Critically Ill Thrombocytopenic Patients
24. Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
25. Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation.
26. Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial
27. ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning
28. S278: CEREBRAL HEMODYNAMICS AND OXYGEN METABOLISM IN PATIENTS WITH MILD AND SEVERE SICKLE CELL DISEASE AND THALASSEMIA
29. P1421: THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE
30. Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps
31. Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial
32. Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease
33. A multimodal pain protocol for treatment of vaso‐occlusive crisis in patients with sickle cell disease: Implementation and evaluation
34. Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia
35. Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis
36. Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML
37. Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population
38. Venous Blood Oxygenation Measurements Using TRUST and T2‐TRIR MRI During Hypoxic and Hypercapnic Gas Challenges.
39. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains
40. Clinical Impact of Polymerase Chain Reaction–based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
41. Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet
42. The association between renal function decline and disease severity in sickle cell disease
43. Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial
44. The predictive value of the modified early warning score for admission to the intensive care unit in patients with a hematologic malignancy-A multicenter observational study
45. Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial
46. Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis:A Prospective Multicenter Study
47. Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients:a multicentre, prospective, cluster randomised, crossover clinical trial
48. Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population
49. Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial
50. One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.